SM
CLVS

Sabby Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Sabby Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-420
Closed -$1.87M – 337
2016
Q4 		$1.87M Sell
420
-1,671
-80% -$58.8K 0.11% 108
2016
Q3 		$7.54M Buy
2,091
+1,988
+1,930% +$42.7K 0.28% 52
2016
Q2 		$141K Buy
103
+3
+3% +$44 0.01% 259
2016
Q1 		$192K Buy
+100
New +$2.12K 0.01% 259
2014
Q3 		– Sell
-206
Closed -$853K – 309
2014
Q2 		$853K Sell
206
-794
-79% -$40.9K 0.04% 163
2014
Q1 		$6.93M Buy
+1,000
New +$73.4K 0.39% 52

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sabby Management's CLVS Position: Q3 2017 in Review

Sabby Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2017, closing a stake of 7,065 shares — an estimated $560K sold.

Sabby Management first reported a position in CLVS in Q2 2014 and held it in 5 quarters. The position peaked at $828K in Q2 2014. 255 funds tracked by Wall St. Rank hold CLVS as of Q3 2017.

  • Sabby Management reported no remaining Clovis Oncology, Inc. position as of Q3 2017 after selling out during the quarter.
  • Sabby Management sold 7,065 Clovis Oncology, Inc. shares in Q3 2017, an estimated $560K.
  • Sabby Management first reported a position in Clovis Oncology, Inc. in Q2 2014 and held it in 5 quarters.
  • Sabby Management's Clovis Oncology, Inc. position peaked at $828K in Q2 2014.
  • 255 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.